Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Hereditary Angioedema Therapeutic Market Size Growth Rate by Type: 2018 VS 2024 VS 2034
1.2.2 Intravenous
1.2.3 Subcutaneous
1.2.4 Oral
1.3 Market by Application
1.3.1 Global Hereditary Angioedema Therapeutic Market Growth by Application: 2018 VS 2024 VS 2034
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Hereditary Angioedema Therapeutic Market Perspective (2018-2034)
2.2 Hereditary Angioedema Therapeutic Growth Trends by Region
2.2.1 Global Hereditary Angioedema Therapeutic Market Size by Region: 2018 VS 2024 VS 2034
2.2.2 Hereditary Angioedema Therapeutic Historic Market Size by Region (2018-2023)
2.2.3 Hereditary Angioedema Therapeutic Forecasted Market Size by Region (2024-2034)
2.3 Hereditary Angioedema Therapeutic Market Dynamics
2.3.1 Hereditary Angioedema Therapeutic Industry Trends
2.3.2 Hereditary Angioedema Therapeutic Market Drivers
2.3.3 Hereditary Angioedema Therapeutic Market Challenges
2.3.4 Hereditary Angioedema Therapeutic Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Hereditary Angioedema Therapeutic Players by Revenue
3.1.1 Global Top Hereditary Angioedema Therapeutic Players by Revenue (2018-2023)
3.1.2 Global Hereditary Angioedema Therapeutic Revenue Market Share by Players (2018-2023)
3.2 Global Hereditary Angioedema Therapeutic Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Hereditary Angioedema Therapeutic Revenue
3.4 Global Hereditary Angioedema Therapeutic Market Concentration Ratio
3.4.1 Global Hereditary Angioedema Therapeutic Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Hereditary Angioedema Therapeutic Revenue in 2024
3.5 Hereditary Angioedema Therapeutic Key Players Head office and Area Served
3.6 Key Players Hereditary Angioedema Therapeutic Product Solution and Service
3.7 Date of Enter into Hereditary Angioedema Therapeutic Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Hereditary Angioedema Therapeutic Breakdown Data by Type
4.1 Global Hereditary Angioedema Therapeutic Historic Market Size by Type (2018-2023)
4.2 Global Hereditary Angioedema Therapeutic Forecasted Market Size by Type (2024-2034)
5 Hereditary Angioedema Therapeutic Breakdown Data by Application
5.1 Global Hereditary Angioedema Therapeutic Historic Market Size by Application (2018-2023)
5.2 Global Hereditary Angioedema Therapeutic Forecasted Market Size by Application (2024-2034)
6 North America
6.1 North America Hereditary Angioedema Therapeutic Market Size (2018-2034)
6.2 North America Hereditary Angioedema Therapeutic Market Growth Rate by Country: 2018 VS 2024 VS 2034
6.3 North America Hereditary Angioedema Therapeutic Market Size by Country (2018-2023)
6.4 North America Hereditary Angioedema Therapeutic Market Size by Country (2024-2034)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Hereditary Angioedema Therapeutic Market Size (2018-2034)
7.2 Europe Hereditary Angioedema Therapeutic Market Growth Rate by Country: 2018 VS 2024 VS 2034
7.3 Europe Hereditary Angioedema Therapeutic Market Size by Country (2018-2023)
7.4 Europe Hereditary Angioedema Therapeutic Market Size by Country (2024-2034)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Hereditary Angioedema Therapeutic Market Size (2018-2034)
8.2 Asia-Pacific Hereditary Angioedema Therapeutic Market Growth Rate by Region: 2018 VS 2024 VS 2034
8.3 Asia-Pacific Hereditary Angioedema Therapeutic Market Size by Region (2018-2023)
8.4 Asia-Pacific Hereditary Angioedema Therapeutic Market Size by Region (2024-2034)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Hereditary Angioedema Therapeutic Market Size (2018-2034)
9.2 Latin America Hereditary Angioedema Therapeutic Market Growth Rate by Country: 2018 VS 2024 VS 2034
9.3 Latin America Hereditary Angioedema Therapeutic Market Size by Country (2018-2023)
9.4 Latin America Hereditary Angioedema Therapeutic Market Size by Country (2024-2034)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Hereditary Angioedema Therapeutic Market Size (2018-2034)
10.2 Middle East & Africa Hereditary Angioedema Therapeutic Market Growth Rate by Country: 2018 VS 2024 VS 2034
10.3 Middle East & Africa Hereditary Angioedema Therapeutic Market Size by Country (2018-2023)
10.4 Middle East & Africa Hereditary Angioedema Therapeutic Market Size by Country (2024-2034)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 BioCryst Pharma
11.1.1 BioCryst Pharma Company Detail
11.1.2 BioCryst Pharma Business Overview
11.1.3 BioCryst Pharma Hereditary Angioedema Therapeutic Introduction
11.1.4 BioCryst Pharma Revenue in Hereditary Angioedema Therapeutic Business (2018-2023)
11.1.5 BioCryst Pharma Recent Development
11.2 Ionis Pharma
11.2.1 Ionis Pharma Company Detail
11.2.2 Ionis Pharma Business Overview
11.2.3 Ionis Pharma Hereditary Angioedema Therapeutic Introduction
11.2.4 Ionis Pharma Revenue in Hereditary Angioedema Therapeutic Business (2018-2023)
11.2.5 Ionis Pharma Recent Development
11.3 Pharming Group
11.3.1 Pharming Group Company Detail
11.3.2 Pharming Group Business Overview
11.3.3 Pharming Group Hereditary Angioedema Therapeutic Introduction
11.3.4 Pharming Group Revenue in Hereditary Angioedema Therapeutic Business (2018-2023)
11.3.5 Pharming Group Recent Development
11.4 CSL Limited
11.4.1 CSL Limited Company Detail
11.4.2 CSL Limited Business Overview
11.4.3 CSL Limited Hereditary Angioedema Therapeutic Introduction
11.4.4 CSL Limited Revenue in Hereditary Angioedema Therapeutic Business (2018-2023)
11.4.5 CSL Limited Recent Development
11.5 Shire
11.5.1 Shire Company Detail
11.5.2 Shire Business Overview
11.5.3 Shire Hereditary Angioedema Therapeutic Introduction
11.5.4 Shire Revenue in Hereditary Angioedema Therapeutic Business (2018-2023)
11.5.5 Shire Recent Development
11.6 Attune Pharma
11.6.1 Attune Pharma Company Detail
11.6.2 Attune Pharma Business Overview
11.6.3 Attune Pharma Hereditary Angioedema Therapeutic Introduction
11.6.4 Attune Pharma Revenue in Hereditary Angioedema Therapeutic Business (2018-2023)
11.6.5 Attune Pharma Recent Development
11.7 Adverum Biotechnologies
11.7.1 Adverum Biotechnologies Company Detail
11.7.2 Adverum Biotechnologies Business Overview
11.7.3 Adverum Biotechnologies Hereditary Angioedema Therapeutic Introduction
11.7.4 Adverum Biotechnologies Revenue in Hereditary Angioedema Therapeutic Business (2018-2023)
11.7.5 Adverum Biotechnologies Recent Development
11.8 KalVista Pharma
11.8.1 KalVista Pharma Company Detail
11.8.2 KalVista Pharma Business Overview
11.8.3 KalVista Pharma Hereditary Angioedema Therapeutic Introduction
11.8.4 KalVista Pharma Revenue in Hereditary Angioedema Therapeutic Business (2018-2023)
11.8.5 KalVista Pharma Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Hereditary Angioedema Therapeutic Market Size Growth Rate by Type (US$ Million): 2018 VS 2024 VS 2034
Table 2. Key Players of Intravenous
Table 3. Key Players of Subcutaneous
Table 4. Key Players of Oral
Table 5. Global Hereditary Angioedema Therapeutic Market Size Growth by Application (US$ Million): 2018 VS 2024 VS 2034
Table 6. Global Hereditary Angioedema Therapeutic Market Size by Region (US$ Million): 2018 VS 2024 VS 2034
Table 7. Global Hereditary Angioedema Therapeutic Market Size by Region (2018-2023) & (US$ Million)
Table 8. Global Hereditary Angioedema Therapeutic Market Share by Region (2018-2023)
Table 9. Global Hereditary Angioedema Therapeutic Forecasted Market Size by Region (2024-2034) & (US$ Million)
Table 10. Global Hereditary Angioedema Therapeutic Market Share by Region (2024-2034)
Table 11. Hereditary Angioedema Therapeutic Market Trends
Table 12. Hereditary Angioedema Therapeutic Market Drivers
Table 13. Hereditary Angioedema Therapeutic Market Challenges
Table 14. Hereditary Angioedema Therapeutic Market Restraints
Table 15. Global Hereditary Angioedema Therapeutic Revenue by Players (2018-2023) & (US$ Million)
Table 16. Global Hereditary Angioedema Therapeutic Market Share by Players (2018-2023)
Table 17. Global Top Hereditary Angioedema Therapeutic Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hereditary Angioedema Therapeutic as of 2024)
Table 18. Ranking of Global Top Hereditary Angioedema Therapeutic Companies by Revenue (US$ Million) in 2024
Table 19. Global 5 Largest Players Market Share by Hereditary Angioedema Therapeutic Revenue (CR5 and HHI) & (2018-2023)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Hereditary Angioedema Therapeutic Product Solution and Service
Table 22. Date of Enter into Hereditary Angioedema Therapeutic Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Hereditary Angioedema Therapeutic Market Size by Type (2018-2023) & (US$ Million)
Table 25. Global Hereditary Angioedema Therapeutic Revenue Market Share by Type (2018-2023)
Table 26. Global Hereditary Angioedema Therapeutic Forecasted Market Size by Type (2024-2034) & (US$ Million)
Table 27. Global Hereditary Angioedema Therapeutic Revenue Market Share by Type (2024-2034)
Table 28. Global Hereditary Angioedema Therapeutic Market Size by Application (2018-2023) & (US$ Million)
Table 29. Global Hereditary Angioedema Therapeutic Revenue Market Share by Application (2018-2023)
Table 30. Global Hereditary Angioedema Therapeutic Forecasted Market Size by Application (2024-2034) & (US$ Million)
Table 31. Global Hereditary Angioedema Therapeutic Revenue Market Share by Application (2024-2034)
Table 32. North America Hereditary Angioedema Therapeutic Market Size Growth Rate by Country (US$ Million): 2018 VS 2024 VS 2034
Table 33. North America Hereditary Angioedema Therapeutic Market Size by Country (2018-2023) & (US$ Million)
Table 34. North America Hereditary Angioedema Therapeutic Market Size by Country (2024-2034) & (US$ Million)
Table 35. Europe Hereditary Angioedema Therapeutic Market Size Growth Rate by Country (US$ Million): 2018 VS 2024 VS 2034
Table 36. Europe Hereditary Angioedema Therapeutic Market Size by Country (2018-2023) & (US$ Million)
Table 37. Europe Hereditary Angioedema Therapeutic Market Size by Country (2024-2034) & (US$ Million)
Table 38. Asia-Pacific Hereditary Angioedema Therapeutic Market Size Growth Rate by Region (US$ Million): 2018 VS 2024 VS 2034
Table 39. Asia-Pacific Hereditary Angioedema Therapeutic Market Size by Region (2018-2023) & (US$ Million)
Table 40. Asia-Pacific Hereditary Angioedema Therapeutic Market Size by Region (2024-2034) & (US$ Million)
Table 41. Latin America Hereditary Angioedema Therapeutic Market Size Growth Rate by Country (US$ Million): 2018 VS 2024 VS 2034
Table 42. Latin America Hereditary Angioedema Therapeutic Market Size by Country (2018-2023) & (US$ Million)
Table 43. Latin America Hereditary Angioedema Therapeutic Market Size by Country (2024-2034) & (US$ Million)
Table 44. Middle East & Africa Hereditary Angioedema Therapeutic Market Size Growth Rate by Country (US$ Million): 2018 VS 2024 VS 2034
Table 45. Middle East & Africa Hereditary Angioedema Therapeutic Market Size by Country (2018-2023) & (US$ Million)
Table 46. Middle East & Africa Hereditary Angioedema Therapeutic Market Size by Country (2024-2034) & (US$ Million)
Table 47. BioCryst Pharma Company Detail
Table 48. BioCryst Pharma Business Overview
Table 49. BioCryst Pharma Hereditary Angioedema Therapeutic Product
Table 50. BioCryst Pharma Revenue in Hereditary Angioedema Therapeutic Business (2018-2023) & (US$ Million)
Table 51. BioCryst Pharma Recent Development
Table 52. Ionis Pharma Company Detail
Table 53. Ionis Pharma Business Overview
Table 54. Ionis Pharma Hereditary Angioedema Therapeutic Product
Table 55. Ionis Pharma Revenue in Hereditary Angioedema Therapeutic Business (2018-2023) & (US$ Million)
Table 56. Ionis Pharma Recent Development
Table 57. Pharming Group Company Detail
Table 58. Pharming Group Business Overview
Table 59. Pharming Group Hereditary Angioedema Therapeutic Product
Table 60. Pharming Group Revenue in Hereditary Angioedema Therapeutic Business (2018-2023) & (US$ Million)
Table 61. Pharming Group Recent Development
Table 62. CSL Limited Company Detail
Table 63. CSL Limited Business Overview
Table 64. CSL Limited Hereditary Angioedema Therapeutic Product
Table 65. CSL Limited Revenue in Hereditary Angioedema Therapeutic Business (2018-2023) & (US$ Million)
Table 66. CSL Limited Recent Development
Table 67. Shire Company Detail
Table 68. Shire Business Overview
Table 69. Shire Hereditary Angioedema Therapeutic Product
Table 70. Shire Revenue in Hereditary Angioedema Therapeutic Business (2018-2023) & (US$ Million)
Table 71. Shire Recent Development
Table 72. Attune Pharma Company Detail
Table 73. Attune Pharma Business Overview
Table 74. Attune Pharma Hereditary Angioedema Therapeutic Product
Table 75. Attune Pharma Revenue in Hereditary Angioedema Therapeutic Business (2018-2023) & (US$ Million)
Table 76. Attune Pharma Recent Development
Table 77. Adverum Biotechnologies Company Detail
Table 78. Adverum Biotechnologies Business Overview
Table 79. Adverum Biotechnologies Hereditary Angioedema Therapeutic Product
Table 80. Adverum Biotechnologies Revenue in Hereditary Angioedema Therapeutic Business (2018-2023) & (US$ Million)
Table 81. Adverum Biotechnologies Recent Development
Table 82. KalVista Pharma Company Detail
Table 83. KalVista Pharma Business Overview
Table 84. KalVista Pharma Hereditary Angioedema Therapeutic Product
Table 85. KalVista Pharma Revenue in Hereditary Angioedema Therapeutic Business (2018-2023) & (US$ Million)
Table 86. KalVista Pharma Recent Development
Table 87. Research Programs/Design for This Report
Table 88. Key Data Information from Secondary Sources
Table 89. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Hereditary Angioedema Therapeutic Market Size Comparison by Type (2024-2034) & (US$ Million)
Figure 2. Global Hereditary Angioedema Therapeutic Market Share by Type: 2024 VS 2034
Figure 3. Intravenous Features
Figure 4. Subcutaneous Features
Figure 5. Oral Features
Figure 6. Global Hereditary Angioedema Therapeutic Market Size Comparison by Application (2024-2034) & (US$ Million)
Figure 7. Global Hereditary Angioedema Therapeutic Market Share by Application: 2024 VS 2034
Figure 8. Hospitals Case Studies
Figure 9. Clinics Case Studies
Figure 10. Others Case Studies
Figure 11. Hereditary Angioedema Therapeutic Report Years Considered
Figure 12. Global Hereditary Angioedema Therapeutic Market Size (US$ Million), Year-over-Year: 2018-2034
Figure 13. Global Hereditary Angioedema Therapeutic Market Size, (US$ Million), 2018 VS 2024 VS 2034
Figure 14. Global Hereditary Angioedema Therapeutic Market Share by Region: 2024 VS 2034
Figure 15. Global Hereditary Angioedema Therapeutic Market Share by Players in 2024
Figure 16. Global Top Hereditary Angioedema Therapeutic Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hereditary Angioedema Therapeutic as of 2024)
Figure 17. The Top 10 and 5 Players Market Share by Hereditary Angioedema Therapeutic Revenue in 2024
Figure 18. North America Hereditary Angioedema Therapeutic Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 19. North America Hereditary Angioedema Therapeutic Market Share by Country (2018-2034)
Figure 20. United States Hereditary Angioedema Therapeutic Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 21. Canada Hereditary Angioedema Therapeutic Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 22. Europe Hereditary Angioedema Therapeutic Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 23. Europe Hereditary Angioedema Therapeutic Market Share by Country (2018-2034)
Figure 24. Germany Hereditary Angioedema Therapeutic Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 25. France Hereditary Angioedema Therapeutic Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 26. U.K. Hereditary Angioedema Therapeutic Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 27. Italy Hereditary Angioedema Therapeutic Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 28. Russia Hereditary Angioedema Therapeutic Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 29. Nordic Countries Hereditary Angioedema Therapeutic Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 30. Asia-Pacific Hereditary Angioedema Therapeutic Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 31. Asia-Pacific Hereditary Angioedema Therapeutic Market Share by Region (2018-2034)
Figure 32. China Hereditary Angioedema Therapeutic Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 33. Japan Hereditary Angioedema Therapeutic Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 34. South Korea Hereditary Angioedema Therapeutic Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 35. Southeast Asia Hereditary Angioedema Therapeutic Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 36. India Hereditary Angioedema Therapeutic Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 37. Australia Hereditary Angioedema Therapeutic Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 38. Latin America Hereditary Angioedema Therapeutic Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 39. Latin America Hereditary Angioedema Therapeutic Market Share by Country (2018-2034)
Figure 40. Mexico Hereditary Angioedema Therapeutic Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 41. Brazil Hereditary Angioedema Therapeutic Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 42. Middle East & Africa Hereditary Angioedema Therapeutic Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 43. Middle East & Africa Hereditary Angioedema Therapeutic Market Share by Country (2018-2034)
Figure 44. Turkey Hereditary Angioedema Therapeutic Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 45. Saudi Arabia Hereditary Angioedema Therapeutic Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 46. BioCryst Pharma Revenue Growth Rate in Hereditary Angioedema Therapeutic Business (2018-2023)
Figure 47. Ionis Pharma Revenue Growth Rate in Hereditary Angioedema Therapeutic Business (2018-2023)
Figure 48. Pharming Group Revenue Growth Rate in Hereditary Angioedema Therapeutic Business (2018-2023)
Figure 49. CSL Limited Revenue Growth Rate in Hereditary Angioedema Therapeutic Business (2018-2023)
Figure 50. Shire Revenue Growth Rate in Hereditary Angioedema Therapeutic Business (2018-2023)
Figure 51. Attune Pharma Revenue Growth Rate in Hereditary Angioedema Therapeutic Business (2018-2023)
Figure 52. Adverum Biotechnologies Revenue Growth Rate in Hereditary Angioedema Therapeutic Business (2018-2023)
Figure 53. KalVista Pharma Revenue Growth Rate in Hereditary Angioedema Therapeutic Business (2018-2023)
Figure 54. Bottom-up and Top-down Approaches for This Report
Figure 55. Data Triangulation
Figure 56. Key Executives Interviewed